Samidorphan, recently Schedule II, approved as psychiatric combo

This month, the Food and Drug Administration (FDA) approved samidorphan and olanzapine, a new combination medication, for the treatment of schizophrenia and bipolar disorder. The medication sponsor is Alkermes, and [...]